CAS: 1282512-48-4 - 1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-

Formula: C₂₄H₂₈N₈O₂

InChI: InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)

InChI key: InChIKey=BEUQXVWXFDOSAQ-UHFFFAOYSA-N

SMILES: O=C(N)C(N1N=CC(=C1)C2=CC=C3C(OCCN4C=C(N=C34)C5=NC(=NN5C(C)C)C)=C2)(C)C

Synonyms:

• 1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
• GDC 0032
• Taselisib
• RG 7604
• 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-1H-pyrazole-1-acetamide

1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-

CAS: 1282512-48-4

• Formula: C₂₄H₂₈N₈O₂
• Purity: %
• Color and Shape: Solid
• Molecular weight: 460.5315

9-BROMO-2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPINE

CAS: 1282512-48-4

• Purity: 95.0%
• Molecular weight: 388.2690124511719

GDC-0032

CAS: 1282512-48-4

Taselisib

CAS: 1282512-48-4

Taselisib (GDC-0032) is an oral PI3K alpha inhibitor with potential cancer-treating properties.

• Formula: C₂₄H₂₈N₈O₂
• Purity: 98.92% - 99.62%
• Color and Shape: Solid
• Molecular weight: 460.53

GDC 0032

CAS: 1282512-48-4

Inhibitor of PI3K kinase isoforms α, δ, and γ

• Formula: C₂₄H₂₈N₈O₂
• Purity: Min. 95%
• Molecular weight: 460.53 g/mol

4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-alpha,alpha-dimethyl-1H-pyrazole-1-acetamide-d7

CAS: 1282512-48-4

• Formula: C₂₄H₂₁D₇N₈O₂
• Color and Shape: Neat
• Molecular weight: 360.361